Share on StockTwits

Smith & Nephew plc (LON:SN)‘s stock had its “outperform” rating reiterated by analysts at Sanford C. Bernstein in a research report issued to clients and investors on Thursday. They currently have a GBX 1,230 ($20.35) target price on the stock. Sanford C. Bernstein’s price target would indicate a potential upside of 17.14% from the company’s current price.

Shares of Smith & Nephew plc (LON:SN) remained flat at GBX 1050.00 during during mid-day trading trading on Thursday. The stock had a trading volume of 872,889 shares. Smith & Nephew plc has a 52 week low of GBX 737.50 and a 52 week high of GBX 1136.00. The stock’s 50-day moving average is GBX 1035.93 and its 200-day moving average is GBX 977.. The company’s market cap is £9.387 billion.

Other equities research analysts have also recently issued reports about the stock. Analysts at Berenberg Bank reiterated a “hold” rating on shares of Smith & Nephew plc in a research note on Tuesday. They now have a GBX 920 ($15.22) price target on the stock. Separately, analysts at Morgan Stanley downgraded shares of Smith & Nephew plc to an “equal weight” rating in a research note on Friday, August 15th. They now have a GBX 1,026 ($16.98) price target on the stock, up previously from GBX 980 ($16.22). Finally, analysts at Societe Generale reiterated a “sell” rating on shares of Smith & Nephew plc in a research note on Tuesday, August 5th. They now have a GBX 700 ($11.58) price target on the stock. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and six have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of GBX 987.41 ($16.34).

Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (LON:SN) and advanced wound management.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.